http://www.reuters.com/article/pressRelease/idUS154656+08-Sep-2009+BW20090908
Teva will present data on the effect of COPAXONE® on the Multiple Sclerosis
Severity Score (MSSS) from the longest ongoing prospective study of an
immunomodulatory therapy in RRMS. In addition, Teva and Active Biotech (NASDAQ
OMX NORDIC: ACTI) will present data on laquinimod, its investigational oral,
once-daily, immunomodulating compound being developed for the treatment of RRMS.
New data on ATL/TV1102, a second generation antisense inhibitor of CD49d, a
subunit of VLA-4, for the treatment of RRMS patients, will be presented as well.
- Forums
- ASX - By Stock
- teva conference presentation
http://www.reuters.com/article/pressRelease/idUS154656+08-Sep-200...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.9¢ | $12.63K | 158.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66500 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 273231 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66500 | 0.076 |
4 | 206988 | 0.075 |
2 | 353708 | 0.074 |
1 | 100000 | 0.072 |
2 | 310000 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 273231 | 2 |
0.082 | 255785 | 2 |
0.083 | 110520 | 2 |
0.084 | 157142 | 2 |
0.085 | 553000 | 3 |
Last trade - 15.26pm 19/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |